Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb 12;16(1):169.
doi: 10.1007/s12672-025-01919-3.

Theoretical perspectives and clinical applications of non-coding RNA in lung cancer metastasis: a systematic review

Affiliations
Review

Theoretical perspectives and clinical applications of non-coding RNA in lung cancer metastasis: a systematic review

Jie Yang et al. Discov Oncol. .

Abstract

Lung cancer is one of the deadliest malignancies worldwide, with distant metastasis being a major cause of death. However, the specific mechanisms of lung cancer metastasis remain unclear. NcRNAs, a widely present type of non-coding RNAs in the body, constitute about 98% of the human genome, lacking protein-coding capacity but involved in various cellular processes such as proliferation, apoptosis, invasion, and migration. Studies have shown that ncRNAs play a crucial role in the metastasis of lung cancer, although research in this area is limited. This review summarizes the biological origins and functions of ncRNAs, their specific roles and mechanisms in lung cancer metastasis, and discusses their potential for early screening and therapeutic applications in lung cancer. Furthermore, it outlines the challenges in translating basic advancements of ncRNAs in lung cancer metastasis into clinical practice.

Keywords: Circular RNA; Long non-coding RNA; Lung cancer; Metastasis; MicroRNA; Non-coding RNA.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: No ethics approval was required for this review that did not involve patients or patient data. Consent for publication: All authors consent to publication. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Mechanism of Lung Cancer Metastasis. Tumors induce angiogenesis through tumor-associated macrophages and various vasoactive factors. Additionally, tumors can recruit endothelial progenitor cells to induce angiogenesis. Due to the lack of tight cell junctions between lymphatic endothelial cells, lymphatic vessels are more permeable than blood vessels. After invading the circulation, cancer cells preferentially bind to platelets. The interaction between platelets and cancer cells facilitates their extravasation into target tissues, where they colonize and thrive in the microenvironment that supports their growth
Fig. 2
Fig. 2
Biogenesis and Functional Effects of ncRNAs. DNA nucleotides are transcribed into primary miRNA transcripts by RNA polymerase II. These are then processed into precursor miRNA within the nucleus. Subsequently, pre-miRNAs are transported to the cytoplasm via exportin-5 and RAN-GTP. In the cytoplasm, they are further processed by the DICER endonuclease into mature miRNAs, which then return to the nucleus to exert their functions. lncRNAs are transcribed by RNA polymerase II from promoter regions of independent genes, producing intronic lncRNA, intergenic lncRNA (lincRNA), and natural antisense transcripts. These lncRNAs exit the nucleus to act as competing endogenous RNAs or interact with proteins. circRNAs are produced by back-splicing of pre-mRNA, forming a closed loop by covalently linking the 5’-head to the 3’-tail. circRNAs can also function as ceRNAs or interact with proteins

Similar articles

References

    1. Chen K, He Y, Wang W, Yuan X, Carbone DP, Yang F. Development of new techniques and clinical applications of liquid biopsy in lung cancer management. Sci Bull. 2024;69:1556–68. - PubMed
    1. Li Y, Yan B, He S. Advances and challenges in the treatment of lung cancer. Biomed Pharmacother. 2023;169: 115891. - PubMed
    1. Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398:535–54. - PubMed
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34. - PubMed
    1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941–53. - PubMed

LinkOut - more resources